Skip to content

Study · Animal study (in vivo) · rat · 2012

1 result

Neuronal activity in the dorsal hippocampus after lateral hypothalamus stimulation: effects of delta-sleep-inducing peptide.

Grigorchuk OS, Umriukhin PE

Bulletin of experimental biology and medicine1 Sept 2012

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Activity measurement

    In Wistar rats, microionophoretic application of DSIP reduced the sensitivity of dorsal hippocampal neurons to lateral hypothalamus stimulation; only 28% of neurons responded.

    In plain wordsIn rats, DSIP made nerve cells in the hippocampus respond less to stimulation of a nearby brain area.

    Outcome
    DecreaseShare of hippocampal neurons responding to lateral hypothalamus stimulation
    Study

    ratn: not reported in source

    Wistar rats, dorsal hippocampus neurons, lateral hypothalamus stimulation
    Outcome group
    Brain and neuronal activity · Nervous system and cognition
    Studied dose
    Dose not stated · microionophoretic applicationAs given in this study (rat).

    Measurements

    neurons responding to stimulation
    28%
    after DSIP application

    Source sentences

    Summary
    After application of delta-sleep-inducing peptide, only 28% neurons responded to stimulation.
    2 context sentences
    Summary · context
    Thus, delta-sleep-inducing peptide reduced the sensitivity of hippocampal neurons to stimulation of the lateral hypothalamus.
    Summary · context
    In Wistar rats preliminary tested in an open field, the reactions of 57 neurons of the dorsal hippocampus were analyzed during lateral hypothalamus stimulation and microionophoretic application of delta-sleep-inducing peptide.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.